Update on Measles
|
|
- Timothy Lane
- 5 years ago
- Views:
Transcription
1 Update on Measles Alan R. Hinman, MD, MPH (With thanks to Jim Goodson, Peter Strebel, and Greg Wallace) Texas Immunization Summit November 6, 2014
2 I do not have any relevant conflicts of interest to disclose.
3 Outline of presentation Background on measles US situation Global situation Conclusion
4 Background on measles Aerosol/airborne transmission Rash ~14 days (7-21) after exposure Infectious 4 days prior through 4 days after rash onset Complications in US Diarrhea 8% Otitis media 7-9% Pneumonia 1-6% Encephalitis % Death % SSPE 0.001%
5
6 US annual burden before vaccine ~500,000 cases/yr reported (3-4M actual) 48,000 hospitalizations 4,000 cases encephalitis deaths
7 Evolution of US Measles Program 1962: Challenge to eradicate measles (Langmuir) 1963: 1-dose recommendation (age 9 mos) 1965: 1-dose recommendation (age 12 mos) 1966: 1 st measles elimination goal (Sencer et al) 1967: 1-dose recommendation (age 15 mos) 1978: 2 nd measles elimination goal (Hinman et al) 1989: 2-dose recommendation (age 15 mos & 4-6 yrs*) : measles resurgence 1993: 3 rd measles elimination goal (initiation of VFC) Outbreaks >1 yr ceased 1994: 2 doses (age mos & 4-6 yrs) 2000: Elimination declared * AAP recommended 2 nd dose before middle school entry
8 Number of cases 600, , , , , ,000 Measles Cases, United States 1963 Vaccine Licensed * 30,000 25,000 20,000 15,000 10,000 5, Resurgence nd Dose Recommended 1993 Vaccines for Children Program 2000 Elimination Declared Year *2014 case count preliminary as of August 29
9 Cases/ 100,000 Reported Measles Incidence United States, * Measles elimination declared 1 case/million *2014 case count preliminary as of August 20 Year
10 No of Cases Measles, United States, 2001-Present* Import Non-Import *2014 case count preliminary as of August 29
11 Number of Cases Measles, United States, * Importations by WHO Region Unknown Western Pacific(WPR) South East Asian(SEAR) European(EUR) Eastern Mediterranean(EMR) African(AFR) American(AMR) Year *2014 case count preliminary as of August 29
12 Measles Outbreaks with >20 Cases, United States, * Year Outbreak Name 2014 Knox County State OH (MO) # of Cases 378 Import Status Genotype Setting Imported (Philippines) 2013 Brooklyn NYC 58 Imported (UK) D KC Metro Tippecanoe County DuPage/Cook County MO/KS (TX/NE) IN 34 IL 30 D9 Community Household/ community 44 Imported-virus B3 Community Imported (Romania) Importedvirus D4 D4 Church/ household Homeschool 2014 Manhattan NYC 25 Imported-virus B3 Community Stokes/Orange County Tarrant/Denton County Hennepin County Brooklyn/ Kings County NC 23 Imported (India) D8 Community TX 21 MN 21 NYC 21 Imported (Indonesia) Imported (Kenya) Imported (Israel, Belgium) D9 B3 D4 Church Shelter Community 1st & last rash onsets 3/24/2014 7/23/2014 3/13/2013 6/9/2013 5/5/2014 7/18/2014 5/16/2005-6/24/2005 5/17/2008-7/3/2008 2/11/2014 3/24/2014 4/5/2013 5/7/2013 7/21/2013 8/21/2013 2/15/2011-4/24/2011 2/17/2008-4/25/2008 Duration 18 weeks 13 weeks Median Age 23 y (early) 13 y (late) 10 y (early) 19 mos (late) Age Range 2 wks 53 y 0 mos 32 y 11 weeks 21 y 2 wks 43 y 6 weeks 12 y 9 mos - 49 y 7 weeks 10 y 8 mos - 43 y 6 weeks 22 y 3 mos 63 y 5 weeks 14 y 12 mos -59 y 5 weeks 11 y 4 mos 44 y 10 weeks 23 m 3 mos - 51 y 10 weeks 15 m 5 mos - 11 y *as of August 29, 2014
13 Measles outbreak response has a high economic burden in the U.S. Year Location Number of cases (outbreaks) Estimated public health cost* 2011 US 107 (16) $ M 2011 Utah 13 (2) >$330, California 12 (1) $125, Arizona 14 (1) $800,000 (limited to cost for 2 hospitals to respond to 7 cases in their facilities) 2005 Indiana 34 (1) $168, Iowa 1 $142,000 *Public health and health care costs expended to control the spread of measles
14 Measles U.S. 2014* 594 cases reported from 22 states 50 importations 23 from the Philippines 46 (92%) US residents 98% cases import-associated 66 cases (11%) hospitalized 18 Outbreaks (defined as 3 or more linked cases) Largest outbreak accounts for 2/3 of cases Top 3 outbreaks account for 3/4 of cases Cases in US residents (N=587) 76% unvaccinated 16% unknown vaccination status (mostly adults) 7% vaccinated (including 5% with 2 or more doses) Among unvaccinated 82% were personal belief exemptors 2% unvaccinated travelers age 6 mos 4 yrs 8% too young to be vaccinated * Provisional reports to CDC through September 19, 2014
15 Measles Outbreaks, USA, st onset latest rash 2014 OUTBREAKS State(s) cases Source Genotype PBE 6/11/2014 6/21/2014 New Haven, CT CT 3 Philippines B3 No 5/30/2014 7/3/2014 King Co., WA WA 16 FSM B3 No Clay Co. MO, Johnson Co., KS Sedgwick Co., MO 26, KS 14,TX 2, IV (imp 5/5/2014 7/14/2014 KC Metro NE 1 43 virus) B3 No 4/25/2014 5/11/2014 Hardeman Co. TN 5 Philippines B3 No 3/22/2014 7/23/2014 Knox/Ashland/Holmes/Ric hland,coschocton Cos. OH 376 MO Philippines D9 Yes 3/25/2014 4/9/2014 San Juan Co. WA 7 SE Asia B3 Yes BC 3/15/2014 3/31/2014 Whatcom Co. WA 6 Canada D8 Yes 3/13/2014 3/28/2014 San Mateo Co. CA 3 Philippines B3 No 3/2/2014 3/17/2014 Orange Co. #2 CA 3 IV (imp virus) B3 2/24/2014 3/15/2014 Orange Co. #3 CA 3 IV (imp virus) B3 Yes 2/18/2014 3/7/2014 San Diego CA 4 Philippines B3 No IV (imp 2/11/2014 3/24/2014 Manhattan NYC 25 virus) B3 2/11/2014 3/20/2014 Orange CA #1 CA 11 IV (imp virus) B3 Yes IV (imp 2/4/2014 3/3/2014 Riverside CA 5 virus) B3 Yes 2/8/2014 2/24/2014 Contra Costa CA 3 Philippines B3 Yes 1/24/2014 1/29/2014 (LAX) WI,NYS,TX 3 LAX (1/17) B3 Yes 1/17/2014 2/1/2014 Los Angeles CA 5 Philippines B3 Yes 12/27/2013 1/10/2014 Marion Co. OR 5 China H1 Yes
16 Measles, United States, Jan Sep 19, 2014 Source of Importations (N=50) WHO Region # of cases Countries of travel African 0 Eastern Mediterranean 1 Pakistan European 6 Dubai/Germany/London (1), Republic of Georgia (1), Netherlands (1), France/Belgium (1), Greece (1), Barcelona/Paris (1) Americas 3 Brazil (1), Canada (1), Chile (1) South-East Asia 9 India (7), Indonesia (1), Thailand/South Korea (1) Western Pacific 31 China (4), Philippines (22), Singapore (1), Saipan (1), Vietnam (1), SE Asia/Philippines (1), FSM (1)
17 Ohio Outbreak 2014 Index cases returned from relief work in Philippines Initially worked up for Dengue 377 reported cases (+ 1 case in MO resident) Affected 9 counties (+ 1 MO resident) Largest and longest outbreak in US since resurgence >10,000 vaccine doses administered in response Limited spread outside Knox County Including large Holmes County community (~30,000) No spread to larger Amish community (~275,000 people) No spread outside Amish community
18
19 Global Burden of Measles Prior to Vaccine: 5-8 million deaths/year 77% decrease in incidence from 2000 to % decrease in deaths from 2000 to 2012 (90% since 1985) 122,000 deaths in 2012 (~14 deaths/hour) Remains a leading cause of vaccine preventable deaths in young children Most deaths in children under 5 years old
20
21
22
23 MCV1 coverage among infants by country, 2013 Source: WHO/UNICEF coverage estimates 2013 revision, July WHO Member States. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization Date of slide: 16 July 2014 <50% (4 countries or 2%) 50-79% (33 countries or 17%) 80-89% (28 countries or 14%) >= 90% (129 countries or 66%) Not available Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved
24 Global and Regional MCV2 Coverage New WHO-UNICEF Estimates 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Global Coverage: 53% Source: WHO/UNICEF coverage estimates 2013 revision. July 2014 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of Slide: 17 July 2014 Global AFR AMR EMR EUR SEAR WPR 24
25 Reported Measles Incidence Rate* May 2013 to Apr 2014 (12M period) <1 (83 countries or 43%) 1 - <5 (28 countries or 14%) 5 - <10 (11 countries or 6%) 10 - <50 (43 countries or 22%) 50 (14 countries or 7%) No data reported to WHO HQ Not applicable!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! (15 countries or 8%)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! *Rate per 1'000'000 population Data source: surveillance DEF file Data in HQ as of 10 June 2014
26 Four strategies to reduce measles mortality improve coverage & quality of routine immunization services ensure a second opportunity for measles immunization (supplemental or routine) establish effective surveillance for measles disease and monitoring of vaccine coverage improve case management including Vitamin A supplementation
27 Global Measles and Rubella Laboratory Network: 711 Laboratories in Sub-National Labs N= 690 labs 34 Prov. Labs Prefect. Labs 191/194 countries served by proficient labs National Laboratories Regional Reference Labs Global Specialised Labs Provincial Labs China Sub-National Labs
28
29 Global progress in preventing measles deaths During , 12.7 M measles deaths were averted globally as a result of immunization activities 8.4 M (66%) averted by maintaining routine immunization coverage at 2000 level 4.3 M (33%) averted as a result of Increases in routine immunization coverage Implementation of measles SIAs
30 Estimated Deaths (1000s) 90% Reduction in Estimated Measles Deaths, ,200 1, During % decrease in incidence 78% decline in deaths 13.8 million deaths averted Source: WHO/IVB estimates, February 2014
31
32 No. of deaths "Global Measles Deaths Drop by 78% but Resurgence likely" Estimated number of measles deaths worldwide, and projections of possible resurgence in measles deaths worldwide, Year Estimates* Projected worst case Projected status quo Worst case: MCV1 level, no follow-up SIAs in 47 priority countries Status quo: MCV1 increases and follow-up SIAs continue, no SIAs in India Wkly Epid Rec, 4 december 2009 No. 49, 2009, 84,
33 No. of reported cases (millions) MCV1 Coverage* (%) % Reduction in reported measles cases Measles global annual reported cases and MCV1 coverage*, Number of cases MCV1 Coverage* * MCV1 coverage: coverage with first dose of measles-containing vaccine as estimated by WHO and UNICEF
34
35 44 Measles Campaigns in 33 Countries in million children reached 24 (55%) achieved 95% coverage 36 of 44 SIAs integrated 1 or more other interventions Measles (10) Measles and OPV (11) Measles and Rubella (10) Measles, Rubella and OPV (2) Vitamin A 14 Not Available De-worming 12 Other interventions 5 Not Applicable Updated on 13 March 2014
36 Measles cases by month and year, WHO European Region, Source: MR reporting to WHO European region Update Date : 25-Aug-2014
37 Measles outbreaks in under-vaccinated groups, WHO European Region, Roma and Sinti communities Croatia Bosnia & Herzegovina Bulgaria Greece Italy Poland Romania Spain Followers of Anthroposophy Austria Germany Netherlands Switzerland Sweden Orthodox Protestant communities Netherlands Traveller communities Ireland Norway Spain United Kingdom Ultra-Orthodox Jewish communities Israel Belgium United Kingdom
38 Public settings for reported measles outbreaks, WHO European Region, Schools and educational facilities Health care settings Austria France Germany Ireland Italy Spain Switzerland UK Bulgaria Croatia Czech Republic Denmark France Greece Latvia Italy Netherlands Spain Switzerland
39 Measles Virus (genotype B3) Spread From Philippines to other countries, Confirmed importation Suspected importation MR campaign 9-59m Sept, 2014
40 Too many children still miss out on measles vaccination Iraq, 0.36 Afghanistan, 0.37 USA, 0.38 Philippines, 0.38 Rest of the world, 7.13 DRC, 0.68 Pakistan, 0.74 Indonesia, 1.11 India, 6.37 Nigeria, 2.66 Ethiopia, million infants unimmunized (MCV1), million infants missed MCV1 in % live in India Nigeria Ethiopia Indonesia Pakistan DRC
41
42 Conclusions Measles has been and still is a major killer of children We have effective strategies to prevent measles We just need to implement them fully Measles eradication is inevitable The only question is WHEN we will do it
The State of Measles and Rubella in the WHO European Region
The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual
More informationUpdate on Progress and Challenges in Achieving Measles and Rubella Targets
Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets
More informationThe Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California
The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California Immunization Coalition, funded through a cooperative agreement
More informationControlling Vaccine Preventable Diseases in the US and Global Immunization Efforts
Controlling Vaccine Preventable Diseases in the US and Global Immunization Efforts Anne Schuchat, MD RADM, US Public Health Service Assistant Surgeon General Director, National Center for Immunization
More informationMeasles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationMeasles 2015: Situational Update, Clinical Guidance, and Vaccination Recommendations
Measles 2015: Situational Update, Clinical Guidance, and Vaccination Recommendations Clinician Outreach and Communication Activity (COCA) Webinar February 19, 2015 Office of Public Health Preparedness
More informationGlobal Measles and Rubella Update November 2018
Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep
More informationGlobal Measles and Rubella Update. April 2018
Global Measles and Rubella Update April 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct
More informationMeasles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationMeasles and Rubella Global Update SAGE April 2018
Measles and Rubella Global Update SAGE April 2018 Alya Dabbagh WHO HQ, IVB/EPI Overview Global update Regional update Surveillance overview M&RI Midterm Review updates Conclusions 2 Measles and Rubella
More informationGlobal Measles and Rubella Update October 2018
Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationThe Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control
The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,
More informationHighlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More information宮村参考人提出資料 資料 2-2
宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar
More information3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
More informationHighlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationHighlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance
No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella
More informationCurrent Situation on Avian Influenza and the pandemic threat
Vaccine-preventable diseases and Immunization, Communicable Diseases Surveillance and Response Current Situation on Avian Influenza and the pandemic threat IVth Joint EC/ECDC/WHO Workshop on Pandemic Influenza
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationEpidemiology of measles in infants younger than 6 months: analysis of surveillance data
Epidemiology of measles in infants younger than 6 months: analysis of surveillance data 2011-2016 An analysis of the epidemiology of measles in infants younger than 6 months was conducted by the U.S. CDC
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%
% of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected
More informationWHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
More informationGlobal Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva
Global Immunization Overview Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global U5 Mortality: Role of Vaccine Preventable Diseases (2008 data) 8.8 million under five deaths Other 20%
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 25% 20% 15% 10%
A report on the epidemiology of selected vaccine-preventable diseases in the European Region This report provides an overview of selected epidemiological characteristics of measles and rubella in the WHO
More informationRECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationIntroduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa
Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Nigeria Center for Disease Control Federal Ministry of Health Abuja July 2015 Outline 1. Measles disease 2. Progress towards
More informationDrug resistance TB in People Living with HIV: research questions and priorities.
Drug resistance TB in People Living with HIV: research questions and priorities. Haileyesus Getahun, MD, PhD. Stop TB Department World Health Organisation Geneva, Switzerland Outline of presentation Definition
More informationGlobal Polio Eradication & Endgame Strategy. December 2015
Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio
More informationThank you for joining, the M&RI webinar will begin shortly
Thank you for joining, the M&RI webinar will begin shortly Please mute your phone or microphone Please do not place the call on hold If you have difficulty with the quality of the connection then here
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationEURO POLIO PAGE Data as of 04 October 2005 (Week 38)
World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:
More informationAccess to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
More informationWCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationVPD in Mediterranean Basin and Black Sea: the Polio case
Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio
More informationUndetectable = Untransmittable. Mariah Wilberg Communications Specialist
Undetectable = Untransmittable Mariah Wilberg Communications Specialist Undetectable=Untransmittable PLWH who get and stay undetectable have effectively no risk of transmitting HIV to their sex partners
More informationWHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI
WHO Rotavirus Vaccine Update 2012 Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO estimates that 453 000 child deaths occurred during 2008 due to rotavirus infection 41057 32653 39144 98621 82% of these deaths occurred
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More informationBack to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office
Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and
More informationGlobal ProhrammeUpdate?
Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus
More informationCritical immunity thresholds for measles elimination
Critical immunity thresholds for measles elimination Sebastian Funk Centre for the Mathematical Modelling of Infectious Diseases London School of Hygiene & Tropical Medicine 19 October, 2017!"vöå"!(}å!öZ&!
More informationTable 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,
Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed
More informationMain developments in past 24 hours
ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance
More informationPolio Eradication and Surveillance. December
Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationWCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
More informationWCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
More informationXDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine
XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution
More informationThe Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
More informationGuidance for Travelers on Temporary Work Assignment Abroad
infected person to immediately seek medical care but, prior to arrival, notify their healthcare provider that they may have been exposed to AI. For more information about avian influenza, see www.cdc.gov/flu/avian/facts.htm,
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationGetting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017
Getting to Zero: On the Verge of Polio Eradication Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption
More informationTotal population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
More informationAnalysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage
A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine
More informationEU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017
EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%
More informationTerms and Conditions. VISA Global Customer Assistance Services
Terms and Conditions VISA Global Customer Assistance Services Visa Global Customer Assistance Services (VGCAS) 1 The Visa Global Customer Assistance Services are co-ordinated by the Global Assistance Centre
More informationWorld Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006
World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,
More informationGlobal EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
More informationPOLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
More informationVaccine Acceptance, Hesitancy and Refusal
Nordic Vaccine Meeting Bergen, Norway, 25 April 2014 Vaccine Acceptance, Hesitancy and Refusal Vaccines have prevented countless deaths. So why do some parents hesitate or refuse? Robb Butler Vaccine-preventable
More informationHepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The
More informationWhy still Polio Donato Greco ECDC polio consultant 14 April 2016
Why still Polio Donato Greco ECDC polio consultant 14 April 2016 A medical student with the last texbook on Communicable diseases! Where there is no chapter on Poliomielitis!!! What can I say o Background
More informationPandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva
Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States
More informationGlobal Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015
Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationTotal population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
More informationHPV Vaccines: Background and Current Status
HPV Vaccines: Background and Current Status Bogota, Colombia, 2007 Jon Kim Andrus, MD HPV and Cervical Cancer Evidence that HPV is essential: Documented molecular studies of cervical cancer Case-control
More informationEUVAC.NET A surveillance network for vaccine-preventable diseases
EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention
More informationVaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO
Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/
More informationRecommended composition of influenza virus vaccines for use in the 2007 influenza season
Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationCANCER FACT SHEETS: BREAST CANCER
CANCER FACT SHEETS: BREAST CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance WHO South-East Asia Region More developed regions WHO African Region WHO Region of the
More informationGlobal landscape analysis and literature review of 2 nd Year of Life immunization platform
Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina
More informationObjective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch
Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf
More informationWEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT
WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT AUG 3 TO SEPT 5, 215 REPORT WEEK 35 CANADA HUMANS During surveillance week 35, ending on Sept 5, 215, three (3 ) human clinical
More informationHepatitis B vaccination worldwide: Lessons learnt and the way forward
Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended
More informationFrom development to delivery: Decision-making for the introduction of a new vaccine
From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines
More informationTotal population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
More informationMethodological issues in the use of anthropometry for evaluation of nutritional status
Methodological issues in the use of anthropometry for evaluation of nutritional status Monika Blössner WHO Department of Nutrition for Health and Development Methodological issues in the use of anthropometry?
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationCEO Board report Seth Berkley MD CEO
CEO Board report Seth Berkley MD CEO Dhaka, Bangladesh, 16 17 November 2011 Bangladesh, November 2011 Meningitis Incidence Children < 12 months Dhaka Shishu / Shishu Shahsta Catchment Area 2008 2011 1800
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More informationEradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011
Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 Why? Polio Crippled for life Primarily affects children We have a historic opportunity. Preventable with vaccine 1955: polio
More informationEuropean monthly measles monitoring (EMMO)
SURVEILLANCE REPORT European monthly measles monitoring (EMMO) Issue 9: 19 March 2012 Main developments In January 2012, 584 cases of measles were reported by the 29 contributing EU and EEA countries.
More informationMeasles: United States, January 1 through June 10, 2011
Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA
More informationEthics Perspective of Immunisation Programs
Ethics Perspective of Immunisation Programs with special reference to Herd Effect T Jacob John Vellore, India Annecy 26 October 2010 Defining Herd immunity and Herd effect. Between participants and nonparticipants
More informationMeasles Hysteria: Mark F. Blaxill Health Choice February 20, 2015
Measles Hysteria: 2015 Mark F. Blaxill Health Choice February 20, 2015 MEASLES MORTALITY IN THE 20 TH CENTURY Deaths per 100K 16 14 12 10 8 6 4 2 Measles had ceased to be a deadly disease long before the
More informationLEBANON. WCPT COUNTRY PROFILE December 2018
LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000
More informationTable 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
More information